Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $23.0 million, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024 [4] - Non-GAAP gross margin in Q4 was 21.5%, compared to 22.6% in Q3 2025 and 18.0% in Q4 2024 [5] - GAAP net loss in Q4 was $3.6 million, or $0.08 per share, compared to a net loss of $1.9 million, or $0.04 per share in Q3 2025 [8][9] - Cash, cash equivalents, and investments increased by $97.2 million to $128.4 million as of December 31, primarily due to a public offering [9] Business Line Data and Key Metrics Changes - Revenue from Indium Phosphide was $8.0 million, primarily from data center applications, while Gallium Arsenide generated $7.0 million [4] - Revenue from consolidated raw material joint ventures was $7.6 million in Q4 2025 [4] - Operating expenses increased to $7.8 million in Q4 from $6.5 million in Q3 2025 [6] Market Data and Key Metrics Changes - Revenue from Asia Pacific accounted for 81.5%, Europe 17.5%, and North America 1% in Q4 2025 [4] - Revenue related to the data center market in China is expected to grow by more than 60% in Q1 2026 compared to Q4 2025 [17] Company Strategy and Development Direction - The company plans to list its subsidiary, Tongmei, on the STAR Market in Shanghai, focusing on the growing demand for indium phosphide substrates driven by AI infrastructure [10] - AXT is expanding its capacity, aiming to double it by the end of 2026, with a focus on six-inch indium phosphide products [18][53] - The company is actively engaging with customers to understand their long-term requirements and align expansion plans globally [18] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment over the number of export permits received in Q4 but noted improvements in Q1 [14] - The company expects sequential revenue growth in Q1, driven by indium phosphide demand for AI data centers [14] - Management highlighted the importance of obtaining export permits as a significant factor for growth [24] Other Important Information - The company has added approximately 25% more capacity and plans to double capacity from Q4 2025 levels by the end of 2026 [18][53] - The raw material business showed growth, with subsidiaries refining high-quality indium and manufacturing PBN crucibles [21] Q&A Session Summary Question: Revenue number for the quarter - The revenue number for Q4 2025 is $23.0 million, with a potential upside if more permits are received [29][30] Question: Insights on the licensing process - The licensing process has become less predictable, with some permits denied but with instructions for resubmission [38][41] Question: Backlog and customer demand - The backlog has increased to over $60 million, with customers ordering further out due to increasing demand forecasts [46][50] Question: Capacity additions and CapEx requirements - The company plans to double capacity by the end of 2026, requiring approximately $30 million for the initial phase [53] Question: Demand and shipment capabilities - If permits were not a restriction, the company could potentially ship around $20 million worth of indium phosphide [88]